INDEPENDENT THINKING. TRACEABLE EVIDENCE.Research edition · 29 October 2026
Modern DosingTHE PRACTITIONER’S PERSPECTIVEA clearer view of
the peptide economy ↗
The provider file / Dossier 351
RESEARCH DOSSIER / NOT AN ENDORSEMENT

BioLongevity Labs

A dated business research record, with the original field-level evidence labels kept intact.

Source snapshot: 2026-10-29. “Verified” below is the source dataset author’s label—not an independent license, safety, quality or clinical audit by Modern Dosing. These pages are excluded from search indexing until reviewed.
Positioning & service claimsverified

'Research-Grade USA Peptides for Sale - Third Party Tested With COA.'

Audienceread

Research-compound buyers prioritizing documentation depth.

Pricing & termspartial

Not published on reviewed homepage.

Clinical relationshipspartial

No clinical care; direct-to-consumer research-compound storefront. Products labeled research use only (RUO), not for human consumption.

Pharmacy & fulfillmentpartial

None; sells research compounds directly, no pharmacy layer.

Advertising snapshotpartial

Google: Google Ads Transparency showed a '0 ads' header with 'F2 Nutrition, LLC' verified-advertiser cards rendering for biolongevitylabs.com (known count/cards inconsistency, 20 Oct 2026) - attribution to BioLongevity Labs UNVERIFIED, treat as lower bound. Meta: Meta Ad Library keyword lookup for 'biolongevitylabs.com' returned no matching ads on 20 Oct 2026. LinkedIn: LinkedIn Ad Library returned 'No results found' on 20 Oct 2026.

Founding yearnot_found

Not established in this pass.

    Foundersnot_found

    Not established in this pass.

      Location & entity contextnot_found

      Not stated on pages reviewed.

        Search visibility samplenot_found

        Not assessed in this pass.

          THE MODERN DOSING WEEKLY

          The peptide news
          that changes your week.

          Evidence-backed developments. The moves that matter. What each means for your practice or business—in one weekly email.